Adam Mendelsohn - May 12, 2025 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Role: Chief Executive Officer, Director
Signature: /s/ Brigid Makes as Attorney-in-fact
Stock symbol: VANI
Transactions as of: May 12, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/14/2025, 08:18 PM
Previous filing: May 14, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mendelsohn Adam	Chief Executive Officer, Director	C/O VIVANI MEDICAL, INC., 1350 S. LOOP ROAD, ALAMEDA	/s/ Brigid Makes as Attorney-in-fact	2025-05-14	0001940008

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VANI	Common Stock Option	Award	$0	+200K		$0.00	200K	May 12, 2025	Common Stock	200K	$1.03	Direct	F1
transaction	VANI	RSUs	Award	$0	+100K		$0.00	100K	May 12, 2025	Common Stock	100K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
F3	The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.